JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Autochthonous cutaneous larva migrans in Chile. A case report].

INTRODUCTION: Cutaneous larva migrans (CLM) is the most common tropical dermatitis. It is caused by nematodes hosted by cats and dogs. Humans act as an accidental reservoir. Clinically, it manifests as a slow-growing, elevated linear, erythematous and pruritic plaque, on the sole of the foot. Diagnosis is clinical, based on the morphology of the lesion associated with recent travel to endemic areas.

OBJECTIVE: To present an autochthonous case of CLM in Chile.

CLINICAL CASE: A 3-year-old boy, presented with a linear lesion on his foot, clinically compatible with CLM. He received a single dose of ivermectin and had complete resolution of the lesion. The patient had no history of travel outside of Chile, but had contact with dogs.

CONCLUSION: CLM is classically described as travellers dermatitis. We present this case, because there are no previous reports of CLM acquired in Chile by children.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app